PureTech Health plc (OTCMKTS:PTCHF) Short Interest Up 93.5% in February

PureTech Health plc (OTCMKTS:PTCHF) saw a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 91,700 shares, a growth of 93.5% from the February 13th total of 47,400 shares. Based on an average daily volume of 1,500 shares, the short-interest ratio is presently 61.1 days.

PureTech Health Price Performance

PureTech Health stock opened at $1.77 on Friday. PureTech Health has a fifty-two week low of $1.66 and a fifty-two week high of $3.00. The stock’s fifty day moving average is $1.75 and its two-hundred day moving average is $1.92.

PureTech Health Company Profile

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.